1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 11 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2001Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAILClayer, M.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Atkins, G.; Findlay, D.
2004Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicinBouralexis, S.; Clayer, M.; Atkins, G.; Labrinidis, A.; Hay, S.; Graves, S.; Findlay, D.; Evdokiou, A.
2002Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanismFindlay, D.; Raggatt, L.; Bouralexis, S.; Hay, S.; Atkins, G.; Evdokiou, A.
2002Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to APO2L/TRIAL-induced apoptosisEvdokiou, A.; Bouralexis, S.; Atkins, G.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.
2001Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosisAtkins, G.; Evdokiou, A.; Bouralexis, S.; Chai, F.; Hay, S.; Clayer, M.; Findlay, D.
2003Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapyBouralexis, S.; Findlay, D.; Atkins, G.; Labrinidis, A.; Hay, S.; Evdokiou, A.
2002Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosisAtkins, G.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Labrinidis, A.; Zannettino, A.; Haynes, D.; Findlay, D.
2000Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cellsKitahama, S.; Gibson, M.; Hatzinikolas, G.; Hay, S.; Kuliwaba, J.; Evdokiou, A.; Atkins, G.; Findlay, D.
2008Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?Labrinidis, A.; Liapis, V.; Thai, L.; Atkins, G.; Vincent, C.; Hay, S.; Sims, N.; Zannettino, A.; Findlay, D.; Evdokiou, A.
2009Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myelomaLabrinidis, A.; Diamond, P.; Martin, S.; Hay, S.; Liapis, V.; Zinonos, I.; Sims, N.; Atkins, G.; Vincent, C.; Ponomarev, V.; Findlay, D.; Zannettino, A.; Evdokiou, A.

Discover